AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comNOV 42 min read$COR

Cencora’s (NYSE:COR) Q3 CY2026 earnings results: revenue in line with expectations

Cencora (COR) reported Q3 CY2026 revenue of $88.35B, up 5.5% YoY, meeting estimates. Adjusted EPS of $4.66 beat expectations by 1.9%. Guidance for fiscal 2027 EPS midpoint missed estimates by 1%. Operating margin was 1%, up from 0% YoY. CEO highlighted strategic acquisitions and record results.

Original reporting
finance.yahoo.com
Published Nov 4, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Cencora’s (NYSE:COR) Q3 CY2026 earnings results: revenue in line with expectations — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CORNeutralMed
01

Why it matters

The earnings release shows solid top‑line performance but a softer outlook, creating a mixed market reaction.

02

Market read

First‑report earnings data for a large‑cap health‑care distributor; likely to influence short‑term price action.

03

What to watch

The acquisition of OneOncology and improving operating margin may provide longer‑term upside not reflected in the short‑term reaction.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Cencora (formerly AmerisourceBergen) is a leading U.S. healthcare distributor with a market cap near $65 B.

Company-level read

Ticker impact

$CORNeutralHigh confidence
Context

Cencora reported Q3 CY2026 revenue in line with expectations and a 1.9% EPS beat, but missed FY2027 guidance.

Expected impact

modest downside as investors price in the guidance shortfall

Evidence & confidence

Revenue met consensus, EPS beat, yet FY2027 EPS guidance fell short, creating mixed signals that typically limit upside and may trigger slight sell pressure.

Market effects

Sector

Healthcare distribution sector may see modest pressure as guidance miss signals slower growth.

Regional

U.S. market participants may adjust exposure to large-cap health distributors.

Global

Limited; impact confined to U.S. listed health‑care distributor space.

Counterpoint

What could challenge this read

Despite guidance miss, the beat on revenue and EPS could support a short‑term bounce if the market overreacts.

Key entities

  • company
    Cencora

    U.S. healthcare distributor reporting Q3 CY2026 results.

Read at source← All news

StoryCencora reports Q4 earnings beat and issues FY2027 EPS guidance

Also covered by

3 outlets

Related articles

NOV 4
$CORMed

Cencora, Inc. (COR): Fiscal Year Ended September 30, 2026 Revenue First Quarter Second Quarter Third Quarter Fourth Quarter Fiscal Year (As Revised) (As Revised)

Cencora, Inc. (COR) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 CENCORA, INC. SUMMARY REPORTABLE SEGMENT INFORMATION (in thousands) (unaudited) The following illustrates revised reportable segment revenue information for the periods indicated: Fiscal Year Ended September 30, 2026 Revenue First Quarter Second Quarter Third Quarter

SEC EDGAR 8-K2 min
NOV 4
$CORHighAI 8/10

Cencora: Fiscal Q4 Earnings Snapshot

Cencora, Inc. (COR) reported fiscal Q4 earnings of $519.4 million, or $2.71 per share, beating analyst expectations. Revenue was $88.35 billion, also exceeding forecasts. The company expects full-year earnings of $19.40 to $19.75 per share.

finance.yahoo.com2 min
NOV 4
$CORHighAI 9/10

Cencora beats estimates on earnings and revenue

Cencora Inc. (NYSE:COR) reported Q4 adjusted EPS of $4.66, beating estimates, with revenue at $88.4B, up 5.5% YoY. The company issued fiscal 2027 EPS guidance of $19.40-$19.75, above consensus. Shares dipped 0.07% in pre-market trading. Cencora also raised its dividend by 10% and reaffirmed long-term growth targets.

investing.com2 min
NOV 4
$CORHighAI 8/10

CENCORA REPORTS FISCAL 2026 FOURTH QUARTER AND FISCAL YEAR END RESULTS

Cencora, Inc. (COR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CENCORA REPORTS FISCAL 2026 FOURTH QUARTER AND FISCAL YEAR END RESULTS Fourth Quarter Revenue of $88.4 Billion up 5.5 Percent. GAAP Diluted EPS of $2.71 and Adjusted Diluted EPS of $4.66 Fiscal Year 2026 Revenue of $337.4 Billion up 5.0 Percent. GAAP Diluted EPS of $

SEC EDGAR 8-K2 min